Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Quantifying muscle phosphocreatine (PCr) resynthesis kinetics during recovery from exercise can be employed as a sensitive and noninvasive in vivo measure of mitochondrial function, or more specifically mitochondrial oxidative capacity, in humans. Here we describe a protocol employing nonlocalized 31P MRS acquisition in the medial gastrocnemius muscle, which, when combined with mDIXON 1H MRI scanning of muscle volume and fat fractions, ensures anatomical localization for 31P MRS acquisition. The protocol involves the performance of in-bore plantar flexor exercise at a predetermined and controlled exercise intensity (50% maximal isometric force) with limb blood flow occluded, thereby ensuring that end-exercise muscle PCr, ADP, and cytosolic pH are well matched across volunteers at the point of end-exercise reinstatement of limb blood flow. This will ensure maximal stimulation of mitochondrial respiration and PCr resynthesis during subsequent resting, nonischemic recovery. Consideration is given to the view that contraction-induced muscle acidosis complicates the interpretation of 31P-derived PCr resynthesis data during exercise recovery and how this can be circumvented.

Original publication

DOI

10.1007/978-1-0716-3315-1_8

Type

Chapter

Book title

Neuromethods

Publication Date

01/01/2023

Volume

204

Pages

137 - 144